Kura oncology to present new data supporting combination of ko-2806 with kras g12c and pan-ras inhibitors

– new preclinical data to be presented at eortc-nci-aacr symposium on molecular targets and cancer therapeutics – – new preclinical data to be presented at eortc-nci-aacr symposium on molecular targets and cancer therapeutics –

NCI Ratings Summary

NCI Quant Ranking